Company · CIK 0000841096
IVORY CAPITAL CORP
Exchange
—
Entity type
operating
Fiscal year end
Jan 31
Headquarters
CO
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- S-1/AIVORY CAPITAL CORP0001193125-05-170790 · 1.4 MBSEC(opens sec.gov)
- 10-QQuarterly update0001193125-05-109064 · 209.5 KBSEC(opens sec.gov)
- S-1IPO registration0001193125-05-072006 · 1.1 MBSEC(opens sec.gov)
- SC 13GIVORY CAPITAL CORP0000950116-05-000774 · 12.4 KBSEC(opens sec.gov)
- 3/AIVORY CAPITAL CORP0000950116-05-000739 · 4.0 KBSEC(opens sec.gov)
- 3IVORY CAPITAL CORP0001181431-05-011738 · 5.1 KBSEC(opens sec.gov)
- 3IVORY CAPITAL CORP0000950116-05-000705 · 3.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-05-031253 · 643.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-05-009467 · 212.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001000096-03-000029 · 7.8 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
13950 BALLANTYNE CORPORATE PLACE UNIT 325
CHARLOTTE, NC, 28277
mailing
13950 BALLANTYNE CORPORATE PLACE UNIT 325
CHARLOTTE, NC, 28277
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies